Skin care brand Ambi is transitioning from one parent company to another. Johnson & Johnson has sold the Ambi brand to Valeant Pharmaceuticals North America. Valeant is a multinational, 17 billion market cap pharmaceutical/OTC company based in Bridgewater, New Jersey. It also owns beauty brand Kinerase, AcneFree, CeraVe and more, in addition to multiple derm brands and other pharmaceutical product brands.
Most Popular in Acquisitions
- 1Coty Takes Controlling Stake in Kylie Cosmetics
- 2Estée Lauder to Acquire Dr. Jart+
- 3Henkel to Acquire DevaCurl
- 4LVMH Purchase of Tiffany Possible
- 5Analysis: Why Shiseido is Acquiring Drunk Elephant
- 6L’Oréal Acquires Clarins Fragrance Divisions
- 7Coty Inc. Appoints Richard Jones as Global Chief Supply Officer
- 8Colgate-Palmolive Expands Into Premium Skin Care with Filorga Acquisition
- 9Nestle Sells off Skin Health Unit
- 10Lenor-Unilever Deal Expands Reach into Asia
Related Content
- Prose Gets $18 Million in Funding to Customize 10,000 Hair Products Per Day
11/26/2018, Jeb Gleason-Allured - L'Occitane Reports Sales Growth Amid Acquisition Rumors
11/28/2018, Jeb Gleason-Allured - Gryphon Investors Acquires RoC Skincare
1/22/2019, Eden Stuart - Drunk Elephant Eyeing (Very Expensive) Sale
1/24/2019, Eden Stuart - Shiseido Sells Ferzea and Encron to Lion
1/31/2019, Eden Stuart
FOLLOW US: